We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
98 hedge funds and large institutions have $357M invested in Lexicon Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
230% more call options, than puts
Call options by funds: $287K | Put options by funds: $87K
163% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 8
77% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 22
62% more capital invested
Capital invested by funds: $221M → $357M (+$136M)
14% more funds holding
Funds holding: 86 → 98 (+12)
1.66% more ownership
Funds ownership: 79.42% → 81.08% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
98
Holders Change
+12
Holders Change %
+13.95%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
39
Reduced
22
Closed
8
Calls
$287K
Puts
$87K
Net Calls
+$200K
Net Calls Change
-$146K
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$51.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10M |
| 3 |
JP Morgan Chase
New York
|
+$5.79M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$5.54M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.69M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.11M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$832K |
| 3 |
IHAM
Integral Health Asset Management
New York
|
-$558K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$558K |
| 5 |
D.E. Shaw & Co
New York
|
-$510K |
